Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.

Use of CPAP and surfactant therapy in newborns with respiratory distress syndrome.

Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.

Association between Apnea of Prematurity and Respiratory Distress Syndrome in Late Preterm Infants: An Observational Study.

Surfactant for neonatal respiratory distress syndrome.

Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.

Raised plasma hypoxanthine levels as a prognostic sign in preterm babies with respiratory distress syndrome treated with natural surfactant.

Surfactant protein A in the course of respiratory distress syndrome.

Why not use a surfactant test for respiratory distress syndrome?

Assessment of dead-space ventilation in patients with acute respiratory distress syndrome: a prospective observational study.

Surfactant replacement therapy for preterm and term neonates with respiratory distress.

Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial.

Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.

Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome.

Bronchoscopic interventions with surfactant and recombinant human deoxyribonuclease for acute respiratory distress syndrome-type respiratory syncytial virus-pneumonia in moderately preterm infants: Case series.

Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.

Determination of Lung Volume and Hemodynamic Changes During High-Frequency Ventilation Recruitment in Preterm Neonates With Respiratory Distress Syndrome.

-) mouse pups.

Prescribing Patterns of Drugs in Acute Respiratory Distress Syndrome (ARDS): An Observational Study.

Surfactant treatment for neonatal respiratory disorders other than respiratory distress syndrome.

Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.

Rachitic respiratory distress in small preterm infants.

The influence of respiratory distress syndrome on heart rate variability in very preterm infants.

Changes in amniotic fluid phospholipids on treatment with glucocorticoids to prevent respiratory distress syndrome.

Efficacy of surfactant at different gestational ages for infants with respiratory distress syndrome.

Suggest Documents

Use of CPAP and surfactant therapy in newborns with respiratory distress syndrome.

Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.

Association between Apnea of Prematurity and Respiratory Distress Syndrome in Late Preterm Infants: An Observational Study.

Surfactant for neonatal respiratory distress syndrome.

Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.

Raised plasma hypoxanthine levels as a prognostic sign in preterm babies with respiratory distress syndrome treated with natural surfactant.

Surfactant protein A in the course of respiratory distress syndrome.

Why not use a surfactant test for respiratory distress syndrome?

Assessment of dead-space ventilation in patients with acute respiratory distress syndrome: a prospective observational study.

Surfactant replacement therapy for preterm and term neonates with respiratory distress.

Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial.

Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.

Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome.

Bronchoscopic interventions with surfactant and recombinant human deoxyribonuclease for acute respiratory distress syndrome-type respiratory syncytial virus-pneumonia in moderately preterm infants: Case series.

Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.

Determination of Lung Volume and Hemodynamic Changes During High-Frequency Ventilation Recruitment in Preterm Neonates With Respiratory Distress Syndrome.

-) mouse pups.

Prescribing Patterns of Drugs in Acute Respiratory Distress Syndrome (ARDS): An Observational Study.

Surfactant treatment for neonatal respiratory disorders other than respiratory distress syndrome.

Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.

Rachitic respiratory distress in small preterm infants.

The influence of respiratory distress syndrome on heart rate variability in very preterm infants.

Changes in amniotic fluid phospholipids on treatment with glucocorticoids to prevent respiratory distress syndrome.

Efficacy of surfactant at different gestational ages for infants with respiratory distress syndrome.

Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.

Recommend Documents

Follow Us